Rhythm Biosciences Limited

Equities

RHY

AU000000RHY2

Biotechnology & Medical Research

Market Closed - Australian S.E. Other stock markets 02:10:55 2024-04-23 am EDT			5-day change	1st Jan Change
0.091 ^AUD	+3.41%		-1.09%	-32.59%

Mar. 21	Rhythm Biosciences Receives AU$2.5 Million Under Rights Issue; Shares Up 3%	MT
Mar. 18	Rhythm Biosciences Limited(ASX:RHY) dropped from S&P/ASX All Ordinaries Index	CI

Rhythm Biosciences Adds Sonic Clinical Services to Colostat Clinical Trial

June 15, 2021 at 06:51 pm EDT

Rhythm Biosciences announced that the latest group to join Rhythm's ColoSTAT® clinical trial is Sonic Clinical Services' Independent Practitioner Network (IPN) Medical Centres. IPN Medical Centres form part of the primary care division of Sonic Healthcare, with more than 2,000 doctors across 160 medical centres nationally. IPN provides more than 10 million patient consultations every year.

Latest news about Rhythm Biosciences Limited

Rhythm Biosciences Receives AU$2.5 Million Under Rights Issue; Shares Up 3%	Mar. 20	MT
Rhythm Biosciences Limited(ASX:RHY) dropped from S&P/ASX All Ordinaries Index	Mar. 17	CI
Rhythm Biosciences Limited(ASX:RHY) dropped from S&P/ASX Emerging Companies Index	Mar. 17	CI
Rhythm Biosciences Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 28	CI
Rhythm Biosciences Seeks to Raise AU$6.6 Million Via Rights Offer; Shares Fall 29%	Feb. 09	MT
Rhythm Biosciences Limited Announces Resignation of Rachel David as Non-Executive Director	Dec. 28	CI
Rhythm Biosciences Ltd Announces the Appointment of James Barrie as Joint Company Secretary, Effective 1 January 2024	Dec. 13	CI
Rhythm Biosciences Identifies Lung Cancer Biomarkers from Blood Samples; Shares Fall 6%	Nov. 23	MT
Rhythm Biosciences Limited Announces Resignation of Paul Smith as CFO	Nov. 15	CI
Rhythm Biosciences Limited Announces Executive Changes	Nov. 15	CI
Rhythm Biosciences Receives First Tranche of R&D Tax Rebate	Nov. 14	MT
Rhythm Biosciences' Breast Cancer Diagnostic Test Shows Positive Results	23-09-22	MT
Rhythm Biosciences Joins Forces to Automate Cancer Test Kit	23-09-13	MT
Rhythm Biosciences Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-31	CI
Rhythm Biosciences Appoints Director to Newly Created Deputy Chair Role	23-07-04	MT
Rhythm Biosciences Signs Deal for UK Entry of Cancer Test	23-05-24	MT
Rhythm Biosciences Secures UK Certification for Diagnostic Test; Shares Surge 89%	23-05-17	MT
Rhythm Biosciences CEO Steps Down; Shares Slump 13%	23-04-19	MT
Rhythm Biosciences Limited Announces Management Changes	23-04-18	CI
Rhythm Biosciences Ltd Announces Executive Changes	23-04-18	CI
Rhythm Biosciences Pulls Out TGA Submission for Colorectal Cancer Diagnostic Kit	23-03-06	MT
Rhythm Biosciences Limited Provides Update to TGA Submission for ColoSTAT® Test-Kit	23-03-05	CI
Rhythm Biosciences Shares Suspended from Australian Bourse	23-03-03	MT
Rhythm Biosciences Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-22	CI
Rhythm Biosciences Retains ISO Certification	23-02-14	MT

Chart Rhythm Biosciences Limited

Duration

Period

More charts

Company Profile

Rhythm Biosciences Limited is an Australia-based medical diagnostics company. The Company is engaged in the development and commercialization of Australian medical diagnostics technology for sale in domestic and international markets. The Company's ColoSTAT a blood-base cancer test, designed for the early detection of colorectal cancer, has been developed initially as an alternative screening test for individuals unable to or unwilling to use available screening modalities. ColoSTAT is indicated to screen adults, aged 40 to 85, at average risk for developing Colorectal Cancer (CRC). The test-kit measures five specific biomarkers in the blood that either increase or decrease in quantity when CRC tumors are present.

Sector

Biotechnology & Medical Research

Calendar

2024-08-28 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Bio Diagnostics & Testing

	1st Jan change	Capi.
RHYTHM BIOSCIENCES LIMITED	-32.59%	13.93M
EXACT SCIENCES CORPORATION	-15.64%	11.33B
IOVANCE BIOTHERAPEUTICS, INC.	+39.24%	3.16B
BGI GENOMICS CO., LTD.	-18.79%	2.04B
GUARDANT HEALTH, INC.	-34.97%	2.14B
VERACYTE, INC.	-27.84%	1.49B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+12.52%	975M
SEEGENE, INC.	-4.37%	731M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-48.78%	364M
CURIOX BIOSYSTEMS CO., LTD	+26.64%	371M

Bio Diagnostics & Testing